Data through FY2026 Q3 (Jun 30, 2026)
City Therapeutics, Inc.
Company profile for City Therapeutics, Inc. covers 7 filings across the reporting window. FY2026 certified median offer: $115,000.
- FY2026 certified median
- $115,000
- Total filings
- 7
- FY2026 25th–75th percentile
- $115,000–$115,000
- Top job title
- Principal Research Associate
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 2 | $121,000 | $120,500 | $121,500 |
| FY2025 | 4 | $133,750 | $115,000 | $153,125 |
| FY2026 (Q1–Q3) | 1 | $115,000 | $115,000 | $115,000 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Principal Research Associate4 filings
- Principal Associate Scientist1 filings
- Senior Manager, CMC Quality Assurance1 filings
- Senior Scientist1 filings
Top cities
- Cambridge7 filings